Skip to content

IMDX IMDX Accrued Royalties (Current)

Accrued Royalties (Current) at other companies

Reservoir Media, Inc. logo
Reservoir Media, Inc.RSVR
$52.32M+10.8%
Scholastic logo
ScholasticSCHL
$82.3M-3.3%
HTF
Heartflow, Inc. Common StockHTFL
$1.05M
LiveOne, Inc. logo
LiveOne, Inc.LVO
$3.48M-36.7%
HealthStream logo
HealthStreamHSTM
$6.59M+17.3%
JAK
Jakks PacificJAKK
$16.99M-34.4%

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:AccruedRoyaltiesCurrent.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's accrued royalties (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's accrued royalties (current)?
IMDX (IMDX) reported accrued royalties (current) of $1.12M in Q1 2026.
How has IMDX's accrued royalties (current) changed year-over-year?
IMDX's accrued royalties (current) decreased by 0.0% year-over-year, from $1.12M to $1.12M.
What is the long-term trend for IMDX's accrued royalties (current)?
Over 3 years (2022 to 2025), IMDX's accrued royalties (current) has grown at a -18.0% compound annual growth rate (CAGR), from $2.02M to $1.12M.
What does accrued royalties (current) mean?
This represents the liability for royalty payments that have been incurred based on sales or usage of licensed technology but remain unpaid as of the balance sheet date. It reflects the company's short-term obligations to third-party intellectual property holders. Tracking this metric provides insight into the cost structure associated with proprietary diagnostic technologies and the timing of cash outflows.